Targeted Biologics and Biosimilars
Biologic drugs that target specific immune molecules (TNF, IL-6, IL-17, IL-23, B-cells) have revolutionised autoimmune treatment. UK trials are now testing the next generation: biosimilars (more affordable versions of existing biologics), dual-target biologics that block two pathways simultaneously, and small molecule inhibitors like JAK inhibitors that can be taken orally instead of by injection.
Inflammatory Bowel Disease Trials
IBD trials in the UK are exploring novel approaches including stem cell therapy for fistulising Crohn's disease, microbiome transplants, and precision medicine that matches treatment to a patient's specific inflammatory profile. The UK IBD BioResource enables rapid trial recruitment across the country.
Dermatology and Skin Conditions
Psoriasis and eczema trials are testing next-generation topical treatments, oral small molecules, and biologic drugs with longer dosing intervals. The field has moved dramatically from steroid-based management to targeted immune modulation, with UK dermatology centres at the forefront of this research.
๐ Conditions
๐ Treatments
โ๏ธ Comparisons
๐ฐ Related Articles
- Autoimmune Clinical Trials UK 2026 Guide โ Guide to autoimmune and inflammatory disease trials
- Rheumatoid Arthritis Clinical Trials UK โ Biologics, JAK inhibitors, and precision medicine for RA
- Psoriasis Clinical Trials UK โ Next-generation biologics and small molecule treatments
Frequently Asked Questions
Find Your Clinical Trial
Search thousands of actively recruiting trials across the UK โ free, instant, no registration.
Search Trials Now Read the Guide